China Cuts Drug Approval Lag but Reimbursement Gaps Persist for Overseas New Medicines
A 16-year analysis of 361 overseas new drugs shows China's regulatory reforms cut approval lag and reimbursement delays, but biologics, ...
A 16-year analysis of 361 overseas new drugs shows China's regulatory reforms cut approval lag and reimbursement delays, but biologics, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine